Knowledge Center
Article / Jun 08, 2009
The View From New Jersey
Source:
C&EN, 8 June, 2009
In the spring of 2003, ËÄÉ«AV opened a small-scale production facility in East Windsor, N.J. As its name implies, the $20 million Technology Transfer Center was intended as a place to develop customers' molecules before moving them to headquarters in Loures, Portugal, for scale-up. Given ËÄÉ«AV's target market of small to midsized drug companies, TTC was meant to boost business with U.S. biotech firms.
Related links
Also in the Knowledge Center
Scientific Article
Scientific Article
Scientific Article